North Chemical Industries Co., Ltd. (SHE:002246)
China · Delayed Price · Currency is CNY 25.90
+0.37 (1.45%)
Apr 16, 2026, 3:04 PM CST
North Chemical Industries Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 2,750 | 1,940 | 2,152 | 2,552 | 2,626 |
Other Revenue | - | 7.08 | 7.67 | 6.94 | 7.64 |
| 2,750 | 1,947 | 2,159 | 2,559 | 2,633 | |
Revenue Growth (YoY) | 41.26% | -9.83% | -15.61% | -2.84% | 11.66% |
Cost of Revenue | 1,943 | 1,600 | 1,710 | 2,091 | 2,132 |
Gross Profit | 807.67 | 347.33 | 449.64 | 467.23 | 501.86 |
Selling, General & Admin | 357.39 | 317.43 | 339.33 | 309.33 | 287.92 |
Research & Development | 141.92 | 115.55 | 83.1 | 117.19 | 110.36 |
Other Operating Expenses | 3.46 | 15.07 | 17.51 | 16.3 | 15.84 |
Operating Expenses | 502.78 | 455.68 | 461.95 | 439.33 | 415.58 |
Operating Income | 304.9 | -108.34 | -12.32 | 27.89 | 86.28 |
Interest Expense | - | -4.07 | -3.61 | -4.68 | -3.33 |
Interest & Investment Income | 3.28 | 32.12 | 36.66 | 35.34 | 37.1 |
Currency Exchange Gain (Loss) | - | 6.23 | 3.67 | 16.33 | -1.65 |
Other Non Operating Income (Expenses) | 17.21 | -0.7 | -0.62 | -0.66 | -0.57 |
EBT Excluding Unusual Items | 325.38 | -74.78 | 23.79 | 74.22 | 117.83 |
Gain (Loss) on Sale of Investments | 2.59 | 0.87 | - | - | - |
Gain (Loss) on Sale of Assets | -0.93 | 11.91 | -1.44 | -2.55 | 1.66 |
Asset Writedown | -19.84 | -2.64 | -1.93 | -0.02 | -45.14 |
Other Unusual Items | - | 31.07 | 28.36 | 23.52 | 33.33 |
Pretax Income | 307.21 | -33.57 | 48.78 | 95.16 | 107.69 |
Income Tax Expense | 55.32 | 1.89 | -3.65 | 6.03 | 11.52 |
Earnings From Continuing Operations | 251.89 | -35.45 | 52.43 | 89.13 | 96.17 |
Minority Interest in Earnings | 11.13 | 7.15 | 3.08 | 4.14 | 25.36 |
Net Income | 263.02 | -28.31 | 55.51 | 93.27 | 121.53 |
Net Income to Common | 263.02 | -28.31 | 55.51 | 93.27 | 121.53 |
Net Income Growth | - | - | -40.48% | -23.26% | 34.77% |
Shares Outstanding (Basic) | 548 | 566 | 555 | 549 | 552 |
Shares Outstanding (Diluted) | 548 | 566 | 555 | 549 | 552 |
Shares Change (YoY) | -3.21% | 1.98% | 1.19% | -0.69% | -1.99% |
EPS (Basic) | 0.48 | -0.05 | 0.10 | 0.17 | 0.22 |
EPS (Diluted) | 0.48 | -0.05 | 0.10 | 0.17 | 0.22 |
EPS Growth | - | - | -41.18% | -22.73% | 37.50% |
Free Cash Flow | 220.36 | 21.37 | -162.18 | -27.89 | 61.78 |
Free Cash Flow Per Share | 0.40 | 0.04 | -0.29 | -0.05 | 0.11 |
Dividend Per Share | - | 0.040 | 0.050 | 0.050 | 0.045 |
Dividend Growth | - | -20.00% | - | 11.11% | 12.50% |
Gross Margin | 29.37% | 17.84% | 20.82% | 18.26% | 19.06% |
Operating Margin | 11.09% | -5.56% | -0.57% | 1.09% | 3.28% |
Profit Margin | 9.56% | -1.45% | 2.57% | 3.65% | 4.61% |
Free Cash Flow Margin | 8.01% | 1.10% | -7.51% | -1.09% | 2.35% |
EBITDA | 405.74 | 3.94 | 92.91 | 121.43 | 183.58 |
EBITDA Margin | 14.75% | 0.20% | 4.30% | 4.75% | 6.97% |
D&A For EBITDA | 100.84 | 112.29 | 105.22 | 93.54 | 97.3 |
EBIT | 304.9 | -108.34 | -12.32 | 27.89 | 86.28 |
EBIT Margin | 11.09% | -5.56% | -0.57% | 1.09% | 3.28% |
Effective Tax Rate | 18.01% | - | - | 6.33% | 10.69% |
Revenue as Reported | - | 1,947 | 2,159 | 2,559 | 2,633 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.